Tag Archives: healthcare

Understanding the Biotech Market in Brazil

LatinAmerica_205x100_Thumbnail copy

The biotechnology market in Brazil has seen enormous activity this year in both the areas of industrial biotechnology and healthcare. In a recent webinar that discussed the latest results of the annual Scientific American Worldview report, panelists were especially excited by the partnering opportunities in Brazil. Mike May, Editorial Director, Scientific American Worldview, commented, “Brazil is, as a country, like a master of partnering. They partner in the country between industry and government. They partner Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Forbes: Sure, We’ll (Eventually) Beat Cancer. But Can We Afford To?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

On May 19, Paul Howard highlighted the promise of immunotherapy for the treatment and possible eventual cure of cancer but emphasized that it is critical to focus on the long-term perspective. Key points raised in the article: ‘Reducing incentives for innovation (and drug development returns are roughly comparable to those in the software industry) and you would encourage investors to park more of their capital in more lucrative investments (think: Snapchat), and less into research for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Testifies at 21st Century Cures Hearing on PCAST

TheHill

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House of Representatives Energy and Commerce Subcommittee on Health Hearing. The Hearing focused on the President’s Council of Advisors on Science and Technology (PCAST) Report on Drug Innovation and key issues related to the 21st Century Cures initiative to examine what steps the Committee can take to accelerate the pace of cures in America. Below is a summary: The Challenge of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

National Healthcare Innovation Summit Shines Spotlight on the Value Equation

115x76-health

The first of the two-day National Healthcare Innovation Summit began and ended trying to answer one question: What constitutes value? Morning keynote speaker Ian Morrison boiled it down to this equation: Value = (Cost + Quality + Security)/Cost However, afternoon speakers struggled to limit the discussion to these variables, wanting to include many others, such as the ability of a health system to pay for innovation, the need to sustain continued innovation, underlying risk of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Driving Innovation through Federal Investments

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving innovation through federal investments. Below are highlights of our written testimony. NIH:  A Driver of the Innovation Pipeline We must continue to invest in scientific discovery.  NIH-supported biomedical research builds the foundation of scientific and clinical knowledge that is widely communicated and used to improve the treatment of patients and underpin the development of new diagnostics, treatments, vaccines, and cures. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,